BioSyent Inc. RX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.06M | 1.71M | 1.43M | 1.95M | 1.46M |
| Total Depreciation and Amortization | 754.70K | 353.50K | 159.00K | 184.40K | 153.70K |
| Total Amortization of Deferred Charges | 3.30K | 3.00K | 3.40K | -37.60K | -- |
| Total Other Non-Cash Items | 143.00K | -39.70K | 77.50K | -38.10K | -19.50K |
| Change in Net Operating Assets | -1.13M | -42.30K | 832.90K | -45.80K | 915.90K |
| Cash from Operations | 1.83M | 1.98M | 2.50M | 2.01M | 2.51M |
| Capital Expenditure | -12.30K | -20.10K | -9.80K | 9.20K | -13.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -16.15M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 660.30K | 2.08M | 1.72M | 318.10K | 137.60K |
| Cash from Investing | 648.00K | -14.09M | 1.71M | 327.40K | 124.10K |
| Total Debt Issued | 0.00 | 8.00M | -- | -- | -- |
| Total Debt Repaid | -2.14M | -4.09M | -51.80K | -49.40K | -48.00K |
| Issuance of Common Stock | 142.80K | 25.20K | 0.00 | 34.40K | 6.30K |
| Repurchase of Common Stock | -1.74M | -1.88M | -12.40K | -16.80K | -23.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -450.80K | -451.60K | -403.90K | -408.80K | -406.70K |
| Other Financing Activities | -15.70K | -12.70K | -11.50K | -12.10K | -12.60K |
| Cash from Financing | -3.16M | 1.04M | -458.20K | -440.70K | -463.00K |
| Foreign Exchange rate Adjustments | -1.60K | 28.60K | -8.90K | 5.10K | -5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -691.60K | -11.04M | 3.75M | 1.90M | 2.16M |